{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:49:45Z","timestamp":1726760985768},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,20]]},"DOI":"10.4103\/0366-6999.225064","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T10:09:55Z","timestamp":1518084595000},"page":"495-497","source":"Crossref","is-referenced-by-count":6,"title":["Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells through Nuclear Factor-\u03baB Signaling Pathway"],"prefix":"10.1097","volume":"131","author":[{"given":"Pei-Pei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Qin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210129","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle cell lymphoma","volume":"34","author":"Cheah","year":"2016","journal-title":"J Clin Oncol"},{"key":"R2-20-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ctrv.2008.09.005","article-title":"New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin","volume":"35","author":"Li-Weber","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"R3-20-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-kappaB a good target for cancer therapy. Hopes and pitfalls?","volume":"8","author":"Baud","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"R4-20-20210129","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"R5-20-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: Opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.225064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:46:21Z","timestamp":1623959181000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201802200-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.225064","relation":{},"ISSN":["0366-6999"],"issn-type":[{"type":"print","value":"0366-6999"}],"subject":[],"published":{"date-parts":[[2018,2,20]]}}}